Harnessing thermo-hydrogen coupling with palladium hydride nanoparticles for superior antitumor therapy
Xinyu Jiang, Kun Li, Penghui Zhao, Dong Li, Jinwen Shi, Yan Zhou, Fei Li, Bin Chen, Haiyan Chen · RSC advances · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In summary, this study presents a PdH nanoparticle platform that achieves synergistic enhancement of oxidative stress in tumor cells through thermo-hydrogen coupling. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in CELL LINES AND CULTURE: 2.6 Human liver cells (LO2), human liver cancer cells (HepG2), and human liver cancer cells (SMMC-7721) were seeded separately in a 96-well plate. In summary, this study presents a PdH nanoparticle platform that achieves synergistic enhancement of oxidative stress in tumor cells through thermo-hydrogen coupling.
What the Researchers Studied
The researchers studied CELL LINES AND CULTURE: 2.6 Human liver cells (LO2), human liver cancer cells (HepG2), and human liver cancer cells (SMMC-7721) were seeded separately in a 96-well plate. The study used a in vitro cell-culture laboratory experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 30 minutes. In summary, this study presents a PdH nanoparticle platform that achieves synergistic enhancement of oxidative stress in tumor cells through thermo-hydrogen coupling. In vitro studies demonstrated that under laser irradiation, PdH nanoparticles efficiently and stably released hydrogen, enhancing intracellular oxidative stress and leading to selective apoptosis in liver cancer cells while sparing normal liver cells.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was CELL LINES AND CULTURE: 2.6 Human liver cells (LO2), human liver cancer cells (HepG2), and human liver cancer cells (SMMC-7721) were seeded separately in a 96-well plate. The study used a in vitro cell-culture laboratory experiment. The reported treatment duration was 30 minutes.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.